CARLISLE COMPANIES INCORPORATED (CSL) Spending and interest coverage
- R&D / revenue · 12 months: Value 0.96%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.65%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 0.96% | Research and development expense / revenue. Period ending 2026-06-30. $48.80M ÷ $5.10B × 100 ≈ 0.96% |
| Stock-based compensation / revenue · 12 months | 0.65% | Share-based compensation / revenue. Period ending 2026-06-30. $33.20M ÷ $5.10B × 100 ≈ 0.65% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 48.80M USD | Research and Development Expense |
| Revenue | 5.10B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 33.20M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.02B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $48.80M | $5.10B | $33.20M | $1.02B | (m) | 0.96% | 0.65% | (m) | (m) |
| 2026-03-31 | $48.50M | $4.98B | $32.60M | $999.20M | (m) | 0.97% | 0.66% | (m) | (m) |
| 2025-12-31 | $47.10M | $5.02B | $34.80M | $1.00B | (m) | 0.94% | 0.69% | (m) | (m) |
| 2025-09-30 | $43.00M | $5.02B | $34.50M | $1.04B | (m) | 0.86% | 0.69% | (m) | (m) |
| 2025-06-30 | $38.70M | $5.00B | $34.80M | $1.06B | (m) | 0.77% | 0.70% | (m) | (m) |
| 2025-03-31 | $36.90M | $5.00B | $28.80M | $1.10B | (m) | 0.74% | 0.58% | (m) | (m) |
| 2024-12-31 | $35.40M | $5.00B | $30.10M | $1.14B | (m) | 0.71% | 0.60% | (m) | (m) |
| 2024-09-30 | $34.60M | $5.01B | $34.20M | $1.17B | (m) | 0.69% | 0.68% | (m) | (m) |
| 2024-06-30 | $33.70M | $4.93B | $35.30M | $1.16B | (m) | 0.68% | 0.72% | (m) | (m) |
| 2024-03-31 | $31.10M | $4.79B | $42.10M | $1.09B | (m) | 0.65% | 0.88% | (m) | (m) |
| 2023-12-31 | $28.70M | $4.59B | $41.50M | $982.80M | (m) | 0.63% | 0.90% | (m) | (m) |
| 2023-09-30 | $57.30M | $5.75B | $46.20M | $1.01B | (m) | 1.00% | 0.80% | (m) | (m) |
| 2023-06-30 | $56.40M | $6.02B | $40.30M | $1.06B | (m) | 0.94% | 0.67% | (m) | (m) |
| 2023-03-31 | $54.00M | $6.27B | $33.00M | $1.14B | (m) | 0.86% | 0.53% | (m) | (m) |
| 2022-12-31 | $50.80M | $6.59B | $31.20M | $1.28B | (m) | 0.77% | 0.47% | (m) | (m) |
| 2022-09-30 | $50.90M | $6.51B | $26.80M | $1.22B | (m) | 0.78% | 0.41% | (m) | (m) |
| 2022-06-30 | $50.60M | $6.03B | $26.50M | $1.04B | (m) | 0.84% | 0.44% | (m) | (m) |
| 2022-03-31 | $51.80M | $5.37B | $14.10M | $760.10M | (m) | 0.97% | 0.26% | (m) | (m) |
| 2021-12-31 | $49.90M | $4.81B | $19.40M | $567.50M | (m) | 1.04% | 0.40% | (m) | (m) |
| 2021-09-30 | $47.30M | $4.42B | $22.90M | $496.30M | (m) | 1.07% | 0.52% | (m) | (m) |
| 2021-06-30 | $55.40M | $4.44B | $23.70M | $480.40M | (m) | 1.25% | 0.53% | (m) | (m) |
| 2021-03-31 | $53.00M | $4.24B | $32.10M | $470.40M | (m) | 1.25% | 0.76% | (m) | (m) |
| 2020-12-31 | $54.80M | $4.25B | $29.90M | $483.60M | (m) | 1.29% | 0.70% | (m) | (m) |
| 2020-09-30 | $58.10M | $4.33B | $27.90M | $513.10M | (m) | 1.34% | 0.65% | (m) | (m) |
| 2020-06-30 | $59.60M | $4.48B | $29.70M | $548.40M | (m) | 1.33% | 0.66% | (m) | (m) |
| 2020-03-31 | $60.90M | $4.77B | $32.00M | $642.20M | (m) | 1.28% | 0.67% | (m) | (m) |
| 2019-12-31 | $60.90M | $4.81B | $26.10M | $654.20M | (m) | 1.27% | 0.54% | (m) | (m) |
| 2019-09-30 | $59.70M | $4.74B | $25.30M | $627.50M | (m) | 1.26% | 0.53% | (m) | (m) |
| 2019-06-30 | $56.80M | $4.65B | $21.80M | $576.50M | (m) | 1.22% | 0.47% | (m) | (m) |
| 2019-03-31 | $55.60M | $4.57B | $23.90M | $529.00M | (m) | 1.22% | 0.52% | (m) | (m) |
| 2018-12-31 | $55.10M | $4.48B | $23.90M | $509.00M | (m) | 1.23% | 0.53% | (m) | (m) |
| 2018-09-30 | $57.80M | $4.73B | $19.10M | $529.50M | (m) | 1.22% | 0.40% | (m) | (m) |
| 2018-06-30 | $57.90M | $4.55B | $19.30M | $524.30M | (m) | 1.27% | 0.42% | (m) | (m) |
| 2018-03-31 | $56.80M | $4.30B | $16.80M | $510.90M | (m) | 1.32% | 0.39% | (m) | (m) |
| 2017-12-31 | $54.90M | $4.09B | $13.20M | $505.70M | (m) | 1.34% | 0.32% | (m) | (m) |
| 2017-09-30 | $52.70M | $3.91B | $12.40M | $513.60M | (m) | 1.35% | 0.32% | (m) | (m) |
| 2017-06-30 | $51.50M | $3.81B | $9.90M | $407.10M | (m) | 1.35% | 0.26% | (m) | (m) |
| 2017-03-31 | $49.60M | $3.74B | $-2.20M | $427.20M | (m) | 1.33% | -0.06% | (m) | (m) |
| 2016-12-31 | $48.10M | $3.68B | $-2.60M | $441.10M | (m) | 1.31% | -0.07% | (m) | (m) |
| 2016-09-30 | $47.40M | $3.66B | $-1.40M | $451.60M | (m) | 1.30% | -0.04% | (m) | (m) |
| 2016-06-30 | $46.40M | $3.64B | $-100.00K | $577.00M | (m) | 1.27% | -0.00% | (m) | (m) |
| 2016-03-31 | $45.30M | $3.63B | $3.00M | $546.10M | (m) | 1.25% | 0.08% | (m) | (m) |
| 2015-12-31 | $42.80M | $3.54B | $2.70M | $501.90M | (m) | 1.21% | 0.08% | (m) | (m) |
| 2015-09-30 | $39.80M | $3.46B | $-6.00M | $465.20M | (m) | 1.15% | -0.17% | (m) | (m) |
| 2015-06-30 | $37.10M | $3.39B | $-6.50M | $437.40M | (m) | 1.10% | -0.19% | (m) | (m) |
| 2015-03-31 | $34.60M | $3.26B | $1.60M | $411.70M | (m) | 1.06% | 0.05% | (m) | (m) |
| 2014-12-31 | $33.80M | $3.20B | $3.30M | $408.30M | (m) | 1.05% | 0.10% | (m) | (m) |
| 2014-09-30 | $32.60M | $3.14B | $12.00M | $411.70M | (m) | 1.04% | 0.38% | (m) | (m) |
| 2014-06-30 | $30.90M | $3.03B | $10.70M | $387.30M | (m) | 1.02% | 0.35% | (m) | (m) |
| 2014-03-31 | $29.90M | $2.96B | $9.70M | $374.40M | (m) | 1.01% | 0.33% | (m) | (m) |
| 2013-12-31 | $29.30M | $2.94B | $11.90M | $366.80M | (m) | 1.00% | 0.40% | (m) | (m) |
| 2013-09-30 | $36.00M | $3.67B | $12.90M | $293.20M | (m) | 0.98% | 0.35% | (m) | (m) |
| 2013-06-30 | $35.30M | $3.61B | $13.10M | $280.40M | (m) | 0.98% | 0.36% | (m) | (m) |
| 2013-03-31 | $34.60M | $3.60B | $11.90M | $398.20M | (m) | 0.96% | 0.33% | (m) | (m) |
| 2012-12-31 | $33.00M | $3.63B | $8.50M | $424.30M | (m) | 0.91% | 0.23% | (m) | (m) |
| 2012-09-30 | $31.70M | $3.57B | $11.80M | $399.80M | (m) | 0.89% | 0.33% | (m) | (m) |
| 2012-06-30 | $30.70M | $3.53B | $15.40M | $371.00M | (m) | 0.87% | 0.44% | (m) | (m) |
| 2012-03-31 | $29.50M | $3.42B | $14.90M | $316.10M | (m) | 0.86% | 0.44% | (m) | (m) |
| 2011-12-31 | $28.70M | $3.22B | $15.70M | $275.10M | (m) | 0.89% | 0.49% | (m) | (m) |
| 2011-09-30 | $27.80M | $3.06B | $15.60M | $249.20M | (m) | 0.91% | 0.51% | (m) | (m) |
| 2011-06-30 | $26.70M | $2.86B | $13.40M | $233.90M | (m) | 0.93% | 0.47% | (m) | (m) |
| 2011-03-31 | $25.80M | $2.67B | $13.50M | $212.50M | (m) | 0.96% | 0.50% | (m) | (m) |
| 2010-12-31 | $23.20M | $2.53B | $13.30M | $196.10M | (m) | 0.92% | 0.53% | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $16.40M | $2.26B | $13.90M | $211.90M | (m) | 0.73% | 0.62% | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $16.20M | $2.86B | $12.00M | $153.10M | (m) | 0.57% | 0.42% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| YUNHONG GREEN CTI LTD. (YHGJ) | United States | $0.007B | -2.79 |